EICHORCondition: Acute Ischemic Stroke · Sponsor: The First Affiliated Hospital of University of Science and Technology of China
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This study aims to evaluate the efficacy and safety of tenecteplase (TNK) intravenous thrombolysis within the extended time window (4.5 to 24 hours) in patients with acute posterior circulation ischemic stroke.
This description comes directly from the study's public registry record.
Wei Hu MD,PhD · +86055162284313 · andinghu@ustc.edu.cn
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of the University of Science and Technology of China | Hefei, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07094763